Calypte Biomedical Corp

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10
from 10-K 2 pages Material contract
12/34/56
EX-10
from 10-K 7 pages Employment Agreement
12/34/56
EX-10
from 10-K 7 pages Employment Agreement
12/34/56
EX-10.203
from 10-K 2 pages Memorandum of Understanding
12/34/56
EX-10.202
from 10-Q 7 pages Subscription Agreement
12/34/56
EX-10.201
from 10-Q 7 pages Subscription Agreement
12/34/56
EX-10.200
from 10-K 13 pages Calypte Biomedical Corporation 2005 Director Incentive Plan
12/34/56
EX-10.146
from 10-K 14 pages Calypte Biomedical Corporation 2004 Incentive Plan
12/34/56
EX-10.198
from 10-Q/A 26 pages Kangplus (China) Holdings, Ltd. (As Transferee) and Marr Technologies Asia Limited and Calypte Biomedical Corporation (As Transferors) Regarding Beijing Marr Bio-Pharmaceutical Co., Ltd. Equity Transfer Agreement July 1 , 2010 1
12/34/56
EX-10.199
from 10-Q 5 pages Debt Conversion Agreement
12/34/56
EX-10.198
from 10-Q 25 pages Kangplus (China) Holdings, Ltd. (As Transferee) and Marr Technologies Asia Limited and Calypte Biomedical Corporation (As Transferors) Regarding Beijing Marr Bio-Pharmaceutical Co., Ltd. Equity Transfer Agreement July 1 , 2010
12/34/56
EX-10.197
from 10-Q 7 pages Dated July 2010 Calypte Biomedical Corporation (1) Marr Technologies B.V. (2) Marr Technologies Limited (3) and Marr Technologies Asia Limited (4) Debt Agreement
12/34/56
EX-10.196
from 10-Q 7 pages Subscription Agreement
12/34/56
EX-10.195
from 10-Q 21 pages Oregon Business Park III L E a S E by and Between Pacific Realty Associates, L.P., a Delaware Limited Partnership and Calypte Biomedical Corporation a Delaware Corporation
12/34/56
EX-10.194
from 10-Q 7 pages Subscription Agreement
12/34/56
EX-10.193
from 8-K 4 pages Resignation and Mutual Release
12/34/56
EX-10.192
from 10-Q 7 pages Subscription Agreement
12/34/56
EX-10.191
from 8-K 9 pages Calypte Biomedical Corporation Warrant
12/34/56
EX-10.190
from 8-K 7 pages Subscription Agreement
12/34/56
EX-10.189
from 8-K 10 pages Calypte Biomedical Corporation Warrant
12/34/56